- Home
- GDHG vs GTBP Comparison
GDHG vs GTBP Comparison
Compare GDHG & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDHG
- GTBP
- Stock Information
- Founded
- GDHG 2008
- GTBP 1965
- Country
- GDHG China
- GTBP United States
- Employees
- GDHG N/A
- GTBP N/A
- Industry
- GDHG Services-Misc. Amusement & Recreation
- GTBP Biotechnology: Pharmaceutical Preparations
- Sector
- GDHG Consumer Discretionary
- GTBP Health Care
- Exchange
- GDHG Nasdaq
- GTBP Nasdaq
- Market Cap
- GDHG 7.4M
- GTBP 6.6M
- IPO Year
- GDHG 2023
- GTBP N/A
- Fundamental
- Price
- GDHG $1.98
- GTBP $1.75
- Analyst Decision
- GDHG
- GTBP Strong Buy
- Analyst Count
- GDHG 0
- GTBP 1
- Target Price
- GDHG N/A
- GTBP $11.00
- AVG Volume (30 Days)
- GDHG 55.2K
- GTBP 31.1K
- Earning Date
- GDHG 02-13-2025
- GTBP 11-14-2024
- Dividend Yield
- GDHG N/A
- GTBP N/A
- EPS Growth
- GDHG N/A
- GTBP N/A
- EPS
- GDHG 1.62
- GTBP N/A
- Revenue
- GDHG $25,549,903.00
- GTBP N/A
- Revenue This Year
- GDHG N/A
- GTBP N/A
- Revenue Next Year
- GDHG N/A
- GTBP N/A
- P/E Ratio
- GDHG $1.22
- GTBP N/A
- Revenue Growth
- GDHG N/A
- GTBP N/A
- 52 Week Low
- GDHG $1.40
- GTBP $1.72
- 52 Week High
- GDHG $59.00
- GTBP $10.66
- Technical
- Relative Strength Index (RSI)
- GDHG 55.59
- GTBP 27.27
- Support Level
- GDHG $1.77
- GTBP $2.41
- Resistance Level
- GDHG $1.97
- GTBP $3.40
- Average True Range (ATR)
- GDHG 0.21
- GTBP 0.35
- MACD
- GDHG 0.06
- GTBP -0.11
- Stochastic Oscillator
- GDHG 82.09
- GTBP 1.43
About GDHG Golden Heaven Group Holdings Ltd.
Golden Heaven Group Holdings Ltd is an offshore holding company. Through the operating entities in China, It manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. The parks collectively contain nearly 159 rides and attractions. The firm's revenue is generated from selling access to rides and attractions, charging fees for special event rentals, and collecting regular rental payments from commercial tenants.
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.